APA (7th ed.) Citation

Tamura, K., Horinouchi, H., Miyake, M., Masuda, K., Shinno, Y., Okuma, Y., . . . Goto, Y. (2025). Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non‐Small Cell Lung Cancer. Thoracic Cancer, 16(16), 1. https://doi.org/10.1111/1759-7714.70145

Chicago Style (17th ed.) Citation

Tamura, Kentaro, Hidehito Horinouchi, Mototaka Miyake, Ken Masuda, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Noboru Yamamoto, and Yasushi Goto. "Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non‐Small Cell Lung Cancer." Thoracic Cancer 16, no. 16 (2025): 1. https://doi.org/10.1111/1759-7714.70145.

MLA (9th ed.) Citation

Tamura, Kentaro, et al. "Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non‐Small Cell Lung Cancer." Thoracic Cancer, vol. 16, no. 16, 2025, p. 1, https://doi.org/10.1111/1759-7714.70145.